Cancer Vaccines

Cellular Anti-Tumor Response Elicited by EBV-Immortalized B Cells

Published in Gene Therapy Weekly, March 11th, 1996

A unique vaccination approach induces cellular anti-tumor immunity.

Many attempts have been made to induce cellular immunity against tumors by using modified tumor cells as anti-cancer vaccines. Unfortunately, even highly antigenic tumors are not completely rejected by the host's immune system with these approaches.

Subsequently, it has been determined that effective priming of the immune system to a particular tumor antigen requires costimulatory signals which can be provided by specialized antigen-presenting cells (APCs), and not the tumor itself. Costimulatory molecules include those in the B7 family and the cytokine family. Protocols which...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1996-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry